BackEucrates Biomedical Acquisition - Warrants (23/10/2027) Overview

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Other Current Liabilities

Latest other current liabilities for EUCRW: $5.1K.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$5080.00

Peer average

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Other Current Liabilities History

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) vs. peers: Other Current Liabilities Comparison

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eucrates Biomedical Acquisition - Warrants (23/10/2027) (EUCRW) FAQ

As of the most recent data (December 2022), EUCRW shows a other current liabilities of $5.1K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCRW's other current liabilities is now $5.1K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition - Warrants (23/10/2027) is outperforming or lagging.

Tracking EUCRW's other current liabilities over time shows whether Eucrates Biomedical Acquisition - Warrants (23/10/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $5.1K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Eucrates Biomedical Acquisition - Warrants (23/10/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $5.1K) with ownership activity and broader fundamentals.